Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers

International Journal of Cancer

Volumn 130, Issue 11, 2012, Pages 2484-2494

  Saulnier, Amandine ^a   Vaissière, Thomas ^a   Yue, Jiping ^a   Siouda, Maha ^a   Malfroy, Marine ^a   Accardi, Rosita ^a   Creveaux, Marion ^a   Sebastian, Sinto ^a   Shahzad, Naveed ^a   Gheit, Tarik ^a   Hussain, Ishraq ^a   Torrente, Mariela ^b   Maffini, Fausto Antonio ^c   Calabrese, Luca ^c   Chiesa, Fausto ^c   Cuenin, Cyrille ^a   Shukla, Ruchi ^a   Fathallah, Ikbal ^a   Matos, Elena ^d   Daudt, Alexander ^e   Koifman, Sergio ^f   Wünsch Filho, Victor ^g   Menezes, Ana M B ^h   Curado, Maria Paula ^a   Zaridze, David ⁱ   Boffetta, Paolo ^a,j,k   Brennan, Paul ^a   Tommasino, Massimo ^a   Herceg, Zdenko ^a   Sylla, Bakary S ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CHILE   (Chile)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

ⁱ N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

more..

Author keywords

cancer; DNA hypermethylation; DOK1; gene silencing; tumour suppressor

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DOK1 GENE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AZACITIDINE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; RISK FACTORS; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84859162851     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26299     Document Type: Article

References (31)

1. Feinberg AP, Tycko B,. The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143-53.
2. Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-28.
3. Bird A,. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6-21.
4. Jaenisch R, Bird A,. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 Suppl: 245-54.
5. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B,. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997; 88: 197-204.
6. Yamanashi Y, Baltimore D,. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 1997; 88: 205-11.
7. Neet K, Hunter T,. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src. Mol Cell Biol 1995; 15: 4908-20.
8. Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP,. Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med 2004; 200: 1689-95.
9. Yasuda T, Shirakata M, Iwama A, Ishii A, Ebihara Y, Osawa M, Honda K, Shinohara H, Sudo K, Tsuji K, Nakauchi H, Iwakura Y, et al. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J Exp Med 2004; 200: 1681-7.
10. Nelms K, Snow AJ, Noben-Trauth K,. Dok1 encoding p62(dok) maps to mouse chromosome 6 and human chromosome 2 in a region of translocation in chronic lymphocytic leukemia. Genomics 1998; 53: 243-5.
11. Lee S, Huang H, Niu Y, Tommasino M, Lenoir G, Sylla BS,. Dok1 expression and mutation in Burkitt's lymphoma cell lines. Cancer Lett 2007; 245: 44-50.
12. Lee S, Roy F, Galmarini CM, Accardi R, Michelon J, Viller A, Cros E, Dumontet C, Sylla BS,. Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia. Oncogene 2004; 23: 2287-97.
13. Sellick GS, Coleman RJ, Talaban RV, Fleischmann C, Rudd MF, Allinson R, Catovsky D, Houlston RS,. Germline mutations in Dok1 do not predispose to chronic lymphocytic leukemia. Leuk Res 2005; 29: 59-61.
14. Niu Y, Roy F, Saltel F, Andrieu-Soler C, Dong W, Chantegrel AL, Accardi R, Thepot A, Foiselle N, Tommasino M, Jurdic P, Sylla BS,. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions. Mol Cell Biol 2006; 26: 4288-301.
15. Ninck S, Reisser C, Dyckhoff G, Helmke B, Bauer H, Herold-Mende C,. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 106: 34-44.
16. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, Ferro G, Paliwal A, Hainaut P, Brennan P, Tost J, Boffetta P, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009; 69: 243-52.
17. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
18. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL,. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992; 89: 1827-31.
19. Di Cristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L, Pandolfi PP,. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med 2001; 194: 275-84.
20. Yamakawa N, Tsuchida K, Sugino H,. The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors. EMBO J 2002; 21: 1684-94.
21. Kashiwada M, Cattoretti G, McKeag L, Rouse T, Showalter BM, Al-Alem U, Niki M, Pandolfi PP, Field EH, Rothman PB,. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5′-phosphatase are required for regulation of CD4+CD25+ T cell development. J Immunol 2006; 176: 3958-65.
22. Zhao M, Janas JA, Niki M, Pandolfi PP, Van Aelst L,. Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis. Mol Cell Biol 2006; 26: 2479-89.
23. Lambert MP, Paliwal A, Vaissiere T, Chemin I, Zoulim F, Tommasino M, Hainaut P, Sylla B, Scoazec JY, Tost J, Herceg Z,. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 2010; 54: 705-15.
24. Lin JC, Jeong S, Liang G, Takai D, Fatemi M, Tsai YC, Egger G, Gal-Yam EN, Jones PA,. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 2007; 12: 432-44.
25. Nan HM, Song YJ, Yun HY, Park JS, Kim H,. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol 2005; 11: 3834-41.
26. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruine AP, Goldbohm RA, van den Brandt PA, Baylin SB, de Goeij AF, Herman JG,. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 2003; 63: 3133-7.
27. Shukla SD, Aroor AR,. Epigenetic effects of ethanol on liver and gastrointestinal injury. World J Gastroenterol 2006; 12: 5265-71.
28. Berger AH, Niki M, Morotti A, Taylor BS, Socci ND, Viale A, Brennan C, Szoke J, Motoi N, Rothman PB, Teruya-Feldstein J, Gerald WL, et al. Identification of DOK genes as lung tumor suppressors. Nat Genet 2010; 42: 216-23.
29. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R,. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 2003; 35: 146-50.
30. Tost J, Dunker J, Gut IG,. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques 2003; 35: 152-6.
31. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP,. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32: e38.